Nasal Breathing Disorders: A Comprehensive 2026 Patient Guide - Back2Sleep

Nasal Breathing Disorders: A Comprehensive 2026 Patient Guide

Nasal Breathing Disorders: A Comprehensive 2026 Patient Guide

Eight conditions explained, with European diagnostic pathways, drug options sold in EU pharmacies, and a clear treatment ladder from saline to surgery.

Nasal breathing disorders affect roughly one in three European adults at some point each year. The eight most common conditions are deviated septum, nasal valve collapse, allergic rhinitis, non-allergic chronic rhinitis, nasal polyps, turbinate hypertrophy, chronic sinusitis, and chronic mouth breathing. Each has distinct causes, different European diagnostic routes, and a specific treatment ladder.

This guide explains each condition in plain language. It maps the European care pathway from primary care to ENT specialist. It compares the most effective treatments, including the Back2Sleep intranasal stent positioned as a first-line non-surgical option for nasal valve collapse and snoring. For a wider view of how nasal anatomy affects sleep, see our primer on nose vs mouth breathing.

Key takeaway
  • Eight separate conditions cause most chronic nasal blockage.
  • Most cases respond to non-surgical care if the right diagnosis is made.
  • Nasal valve collapse is the most missed diagnosis and the easiest to treat at home.
  • EU pharmacies sell most front-line treatments without prescription.
33%
EU adults with annual nasal symptoms
25%
have a clinically deviated septum
13%
prevalence of allergic rhinitis EU
4%
have nasal polyps
Infographic about Nasal Breathing Disorders: A Comprehensive 2026 Patient Guid

How European doctors diagnose nasal breathing disorders

European care pathways start with the general practitioner (GP), médecin traitant in France, Hausarzt in Germany, médico de cabecera in Spain, huisarts in the Netherlands, medico di medicina generale in Italy, or NHS GP in the UK. The GP handles allergy testing and prescribes first-line nasal sprays. Persistent or anatomical cases are referred to an ENT specialist (otorhinolaryngologist, oto-rhino-laryngologiste, HNO-Arzt, otorrinolaringólogo, KNO-arts, otorinolaringoiatra).

The five-step EU diagnostic pathway

  1. Symptom history. Duration, side, triggers, family history, sleep impact.
  2. Anterior rhinoscopy. The GP looks into each nostril with a speculum and light.
  3. Modified Cottle test. Cheek pulled gently outward to test for valve collapse.
  4. Allergy panel. Skin-prick or specific IgE blood test on referral.
  5. ENT endoscopy and imaging. Flexible nasendoscopy, CT scan if structural concern.
Insurance notePublic health systems across the EU (Sécurité Sociale in France, GKV in Germany, NHS in the UK, SSN in Italy, Seguridad Social in Spain, Zorgverzekering in the Netherlands) cover GP and ENT consultations for documented nasal complaints. CT imaging usually requires a specialist referral.

When to see an ENT immediately

Some signs warrant urgent referral rather than a wait-and-see approach.

  • One-sided block lasting more than four weeks.
  • Bleeding, crusting, or numbness localised to one nostril.
  • Loss of smell that does not return after a cold.
  • Visible facial swelling or pain over the cheek or forehead.
  • Snoring with witnessed breathing pauses.
Back2Sleep nasal stent improves nasal airflow

Deviated septum: anatomy, symptoms, and care

A deviated septum is a sideways shift of the wall between the two nasal cavities. About 80 percent of adults have some deviation, but only 20 to 25 percent have a clinically significant block. The deviation can be congenital, from birth shape, or acquired, after a sports injury or childhood facial trauma.

Key symptoms

  • One nostril blocked more than the other.
  • Recurrent sinus infections on the blocked side.
  • Loud snoring that worsens lying on the blocked side.
  • Chronic dryness or nosebleeds from the deviation point.

European treatment ladder

EU ENT specialists step through three tiers before recommending surgery. Read more in our piece on deviated septum and snoring.

Tier Treatment Evidence Typical EU cost
1 Saline rinse + intranasal corticosteroid Reduces edema, opens narrowed channel 10 to 25 euros per month over the counter
2 Intranasal stent worn at night Mechanical opening of the narrow side 39 euros starter kit
3 Septoplasty surgery Permanent realignment, 85 percent satisfaction at one year Covered by EU public systems for documented impact
Practical tip
  • Try the conservative tiers for at least three months before surgical referral.
  • Septoplasty does not improve aesthetics and is purely functional.
  • Combined septorhinoplasty exists but is rarely covered by public insurance.

Nasal valve collapse: the most missed diagnosis

Nasal valve collapse is dynamic narrowing of the soft area inside the nostril, just past the entrance. It happens during inhalation when negative pressure pulls the cartilage inward. Up to 13 percent of chronic nasal obstruction cases are caused by valve collapse, yet it is rarely detected on a quick GP exam.

How the modified Cottle test works

The patient breathes normally while the doctor pulls the cheek outward, opening the valve area. If breathing improves dramatically, valve collapse is confirmed. The test takes 10 seconds, requires no equipment, and any GP can perform it. If your doctor has not done it, ask.

Treatment options for valve collapse

Internal nasal stent

Soft silicone tube placed inside the nostril at night. Opens the valve mechanically. The Back2Sleep stent is CE-certified Class I and available in 4 sizes (XS to L). Available without prescription in EU pharmacies and online from 39 euros.

External nasal strip

Adhesive strip on the outside of the nose. Lifts the nostril walls slightly. Less effective than internal stents and only addresses the upper valve. Roughly 30 percent reduction in snoring intensity in published trials.

Nasal valve surgery

Lateral wall reconstruction or batten graft. Performed by ENT plastic surgeons. Effective in 70 to 80 percent of cases but invasive, with two weeks of recovery. EU public coverage varies by country.

Evidence noteA 2022 European peer-reviewed study in Rhinology reported that internal nasal stents reduced apnea-hypopnea index by 36 percent in patients with mild to moderate obstructive sleep apnea and dynamic valve collapse, providing a low-cost alternative to surgery for selected patients.
Back2Sleep product designed for nose breathers

Allergic rhinitis: the most common cause of chronic congestion

Allergic rhinitis affects roughly 13 percent of European adults and 17 percent of children. It is an inflammatory response to inhaled allergens, with pollen (hay fever) and house-dust mites as the leading triggers. The European Academy of Allergy and Clinical Immunology (EAACI) classifies it as intermittent or persistent, mild or moderate to severe.

Diagnostic clues

  • Sneezing in clusters of 5 or more.
  • Watery clear discharge.
  • Itchy nose, eyes, or throat.
  • Bilateral symptoms (both sides).
  • Seasonal pattern or pet exposure trigger.

EU first-line treatments

  1. Allergen avoidance. Mite-proof covers, HEPA filters, pollen-tracker apps.
  2. Saline rinses. Twice-daily isotonic or hypertonic rinses cut symptoms by 30 to 40 percent.
  3. Second-generation oral antihistamines. Cetirizine, loratadine, desloratadine sold over the counter in most EU pharmacies.
  4. Intranasal corticosteroids. Mometasone, fluticasone over the counter in EU. Apply daily for two to four weeks before judging effect.
  5. Allergen immunotherapy. Sublingual or subcutaneous, prescribed for severe persistent cases. Three to five years of treatment, often partially reimbursed by EU public systems.
CautionDecongestant sprays such as xylometazoline or oxymetazoline are very effective short-term but cause rebound congestion (rhinitis medicamentosa) if used longer than five days. Always read the EU pharmacy leaflet (notice in France, Beipackzettel in Germany).

Non-allergic chronic rhinitis

Non-allergic rhinitis (NAR) is chronic inflammation of the nasal lining without an allergen trigger. It accounts for roughly 25 to 30 percent of all chronic rhinitis cases in Europe. It is diagnosed by exclusion when allergy tests are negative.

Common triggers

  • Cold air, temperature changes, weather fronts.
  • Strong odours: perfume, cleaning products, paint, smoke.
  • Spicy foods (gustatory rhinitis).
  • Hormonal shifts (pregnancy, menstrual cycle, thyroid disease).
  • Medications: ACE inhibitors, beta-blockers, contraceptive pills.
  • Stress and emotional triggers (vasomotor rhinitis).

Treatment that works

Saline rinses, intranasal corticosteroids, and antihistamine sprays such as azelastine remain first line. Avoiding the trigger and writing a daily journal often pinpoints the irritant. For sleep-related congestion, an intranasal stent prevents nighttime collapse without adding medication.

Nasal polyps

Nasal polyps are benign, soft, teardrop-shaped growths in the lining of the nose and sinuses. Around 4 percent of European adults develop them, more often men over 40 and people with asthma or aspirin sensitivity (the Samter triad). Polyps are not cancer, but a one-sided polyp must always be biopsied to rule out a tumour.

Symptoms

  • Persistent stuffy nose despite sprays.
  • Loss of smell (anosmia) and taste.
  • Post-nasal drip and chronic cough.
  • Facial pressure across forehead and cheeks.
  • Snoring that worsens over months.

Treatment options in Europe

Approach How it helps EU access
Topical corticosteroid spray Shrinks small polyps, reduces inflammation Over the counter or GP prescription
Short oral corticosteroid course Rapid shrinkage of large polyps GP or ENT prescription, time-limited
Biologic injections (dupilumab, omalizumab, mepolizumab) Targets type 2 inflammation, reduces polyp size ENT prescription, reimbursed by major EU systems for severe disease
Functional endoscopic sinus surgery (FESS) Removes large polyps and opens sinus drainage Public coverage in all EU-5 countries
EU innovationBiologic therapies (dupilumab) are reimbursed by GKV (Germany), Sécurité Sociale (France), NHS (UK via NICE), and SSN (Italy) for severe chronic rhinosinusitis with nasal polyposis when standard care fails. Reach out to your ENT specialist for eligibility.

Turbinate hypertrophy

The inferior turbinates are bony shelves on each lateral wall covered with erectile tissue that swells and shrinks. Turbinate hypertrophy means the swelling has become permanent due to chronic inflammation, allergy, or anatomy. It produces a stuffy nose that worsens at night when lying down, with side-to-side alternation called the nasal cycle.

Conservative treatment

  1. Intranasal corticosteroids for 8 to 12 weeks.
  2. Saline rinses twice daily.
  3. Allergen control if allergic component present.
  4. Sleep with the head of the bed raised 10 to 15 centimeters.
  5. Trial of an intranasal stent for nighttime obstruction.

When surgery is offered

Persistent severe block after 12 weeks of medical treatment may justify turbinoplasty. EU ENT teams favour minimally invasive techniques: radiofrequency ablation, microdebrider reduction, or coblation. These outpatient procedures take under 30 minutes, recover within a week, and rarely cause empty-nose syndrome when performed conservatively.

Chronic sinusitis

Chronic rhinosinusitis (CRS) is inflammation of the nasal and sinus lining lasting more than 12 weeks. The European Position Paper on Rhinosinusitis (EPOS 2020) is the reference guideline used across EU ENT services. CRS is divided into CRS with polyps (CRSwNP) and CRS without polyps (CRSsNP).

Diagnostic criteria (EPOS)

Two or more symptoms for 12 weeks, plus endoscopy or CT evidence:

  • Nasal blockage or congestion.
  • Discoloured nasal discharge or post-nasal drip.
  • Facial pain or pressure.
  • Reduction or loss of smell.

Stepwise EU treatment

  1. Saline rinses + topical corticosteroid spray. First line for at least 12 weeks.
  2. Short antibiotic course. Only if bacterial superinfection confirmed.
  3. Long-term low-dose macrolide. Considered for refractory CRSsNP under specialist supervision.
  4. Biologics for severe CRSwNP. Dupilumab, mepolizumab, omalizumab.
  5. FESS surgery. Reserved for medical-failure cases.

Chronic mouth breathing

Chronic mouth breathing is the habit of breathing through the mouth instead of the nose during sleep, exercise, or rest. It often develops because nasal breathing has been blocked for years, and the brain rewires the default pattern. By the time the obstruction is treated, the habit persists.

Why it harms health

  • Dries the airway and reduces protective mucus.
  • Bypasses nitric oxide production from the nasal lining (15 to 25 percent of total).
  • Promotes snoring and sleep apnea.
  • Reshapes the face in children: long face, narrow palate, dental crowding.
  • Increases dental caries by drying saliva.

Reversal strategy

Once the underlying nasal obstruction is treated, retraining the breathing pattern takes 4 to 12 weeks. See our guide on how to stop mouth breathing for the full programme.

Reversal protocol
  • Treat the underlying nasal cause first.
  • Use myofunctional exercises to strengthen tongue posture.
  • Keep the mouth closed during the day with conscious cues.
  • Use a nasal stent at night to make nasal breathing comfortable.
  • Consider mouth taping only after a sleep specialist has ruled out apnea.

The master decision tree

Use this ladder to find the right starting point. It is built around symptom dominance, not severity. If two conditions overlap, treat the dominant symptom first.

Dominant symptom Likely cause Step 1 (this week) Step 2 (this month) Step 3 (specialist)
One nostril blocked Deviated septum Saline rinse Intranasal stent + steroid spray ENT for septoplasty
Nostril collapse on inhalation Nasal valve collapse Cottle self-test Intranasal stent (39 euros) ENT for valve graft
Sneezing + itch + watery Allergic rhinitis Avoid allergen, antihistamine Steroid spray daily Allergist for immunotherapy
No allergen, weather-driven Non-allergic rhinitis Saline rinse + azelastine Trigger journal ENT if persistent
Loss of smell + bilateral block Nasal polyps Steroid spray daily GP referral ENT for biologic or FESS
Stuffy at night, alternating sides Turbinate hypertrophy Saline + steroid spray Nasal stent at night ENT for turbinate reduction
Facial pain + thick discharge Chronic sinusitis Saline rinse 2x daily Steroid spray + GP review ENT for FESS
Dry mouth, snoring Chronic mouth breathing Treat underlying cause Myofunctional therapy Sleep clinic if apnea suspected
Where Back2Sleep fitsFor nasal valve collapse, mild deviated septum, turbinate hypertrophy, and snoring driven by nasal blockage, the Back2Sleep intranasal stent is the most affordable non-surgical option. Available at 39 euros for a starter kit with 4 sizes (XS, S, M, L), no prescription required, available direct-to-consumer in EU pharmacies and online with same-day shipping in major EU markets and a 30-day money-back guarantee. It is sold out of pocket; no public reimbursement is required because the price point is comparable to a single co-pay.

Cost comparison: EU treatment options

Treatment cost varies widely. The chart below uses median EU prices in 2026 for adults seen through standard public-system pathways. Out-of-pocket costs reflect what a patient typically pays after public reimbursement in France, Germany, Italy, Spain, and the Netherlands.

Treatment Sticker price Public coverage (FR/DE/IT/ES/NL) Typical out-of-pocket
Saline rinse kit 10 to 20 euros None (over the counter) Full price
Intranasal corticosteroid spray 8 to 15 euros None over the counter; partial if prescribed for chronic disease 5 to 15 euros
Antihistamine tablets 5 to 12 euros Partial reimbursement if prescribed 3 to 10 euros
Allergen immunotherapy 800 to 2,500 euros over 3 to 5 years Partial reimbursement in major EU systems 200 to 800 euros
Back2Sleep starter kit 39 euros None (direct-to-consumer) 39 euros
Septoplasty surgery 2,000 to 4,000 euros Largely covered for documented cases 50 to 500 euros co-pay
FESS for sinusitis 3,000 to 6,000 euros Largely covered 50 to 500 euros co-pay
Biologic therapy (dupilumab) 15,000 to 25,000 euros per year Reimbursed for severe CRSwNP under criteria 0 to several hundred euros

The science of nasal airflow

The nose handles 90 to 95 percent of resting respiration in healthy adults. It heats air from outside temperature to roughly 32 degrees Celsius before reaching the lungs, humidifies it to 90 percent relative humidity, and filters out particles down to 5 micrometres in size. Disrupting any of these functions has effects far beyond a stuffy feeling.

The three resistance zones

Most adults assume the entire nose contributes equally to airflow. In reality, the air encounters three distinct narrow points, each one capable of becoming a problem.

Nasal vestibule

The very entrance of the nostril, lined with skin and stiff hairs. Filters large particles. Rarely a problem unless trauma or surgery has changed the shape.

Internal nasal valve

The narrowest point and the highest resistance area. Bordered by septum medially, lateral cartilage above, and inferior turbinate below. Most chronic blockage centres here.

External nasal valve

The flared part of the nostril held open by lateral wall cartilage. Collapses inward in some adults during deep inhalation, particularly during sleep when muscles relax.

The nitric oxide story

The paranasal sinuses produce nitric oxide (NO), a small molecule that dilates lung blood vessels and improves oxygen exchange. Nasal breathing carries this NO into the lungs with each breath. Mouth breathing bypasses it entirely. Patients with chronic nasal obstruction lose 15 to 25 percent of their normal NO uptake, which contributes to fatigue, exercise intolerance, and elevated blood pressure.

Why nasal breathing matters
  • Conditions inhaled air for the lungs.
  • Filters particles and pathogens.
  • Delivers nitric oxide to lung circulation.
  • Maintains the nasal cycle alternating sides every 2 to 4 hours.
  • Engages the diaphragm more efficiently than mouth breathing.

How sleep amplifies nasal blockage

Daytime nasal obstruction is annoying. Nighttime obstruction is dangerous. Three changes happen during sleep that make any underlying nasal disorder worse.

Position effect

Lying down allows fluid to redistribute from the legs to the head and neck. This rostral fluid shift swells the nasal mucosa and turbinates by 20 to 40 percent compared to standing. Sleeping on the side worsened by deviation increases obstruction sharply.

Muscle tone collapse

During REM sleep, the muscles surrounding the airway lose tone. Pharyngeal walls collapse inward more easily, and the nasal valve also loses its supporting tone. People with marginal valve collapse during the day develop frank obstruction at night.

Neurological compensation

The brain compensates for nasal obstruction during sleep by switching to mouth breathing. Mouth breathing reduces the brake on tongue position, which falls back into the airway and triggers snoring and sleep apnea. The chain is: nasal block, mouth open, tongue back, snore or apnea.

Why nasal disorders affect sleep apneaUp to 50 percent of patients diagnosed with mild to moderate obstructive sleep apnea (OSA) have an underlying nasal contribution. Treating the nasal cause alone can reduce apnea-hypopnea index by 20 to 40 percent in selected patients, even before CPAP.

The role of allergens and pollutants in Europe

Environmental triggers vary across Europe. Knowing which trigger dominates locally helps target the right strategy.

Trigger Peak season Most affected EU regions Best mitigation
Birch pollen March to May Northern Europe (DE, NL, Scandinavia) HEPA filter, antihistamines, immunotherapy
Grass pollen May to August UK, France, Germany, Benelux Pollen-tracker apps, indoor sleep with windows closed
Olive pollen April to June Spain, Italy, Greece, Portugal Local immunotherapy, mask outdoors
Ragweed August to October Hungary, Italy, France, Spain Avoidance, biologics for severe disease
House-dust mites Year-round, peak autumn Coastal and humid regions Mite-proof bedding, dehumidifier, hot wash linens
Mould spores Autumn and winter Northern wet regions, basements Dehumidify, repair leaks, avoid bedrooms with damp
Pet dander Year-round All EU countries Bedroom-free zone, HEPA filter, regular pet bathing
Particulate pollution (PM2.5) Winter peaks Major cities (Paris, Madrid, Milan) Indoor air purifier, urban masks during peaks

Lifestyle adjustments that protect nasal breathing

Even with the right medication or device, lifestyle drives 30 to 50 percent of long-term outcomes. The following changes are inexpensive, evidence-based, and sustainable across all EU countries.

Sleep environment

  1. Keep the bedroom temperature at 18 to 20 degrees Celsius.
  2. Maintain humidity at 40 to 50 percent. Use a humidifier in heated rooms in winter.
  3. Use mite-proof covers for mattress, pillow, and duvet.
  4. Wash bed linen weekly at 60 degrees Celsius to kill dust mites.
  5. Remove carpet and heavy curtains from bedroom if you have allergies.

Daily habits

  1. Saline rinse twice daily during allergy season.
  2. Stay hydrated; thicker mucus blocks more easily.
  3. Avoid alcohol within four hours of bedtime; it dilates blood vessels and worsens swelling.
  4. Avoid late dinners and reflux triggers; nighttime acid reaches the upper airway.
  5. Consider a nasal stent at night during high-risk seasons (allergies, illness, travel).

Exercise and breathing training

  1. Regular aerobic exercise reduces overall airway inflammation and reduces nasal congestion within 4 to 8 weeks.
  2. Buteyko or slow nasal-breathing exercises retrain the default breathing pattern.
  3. Yoga and meditation lower sympathetic tone, which reduces vasomotor reactivity.
  4. Wind-instrument or singing practice strengthens upper airway muscles.

Comparing treatment ladders side by side

The strategy depends on the diagnosis. Use the comparison below to confirm you are pursuing the right ladder for your dominant problem. Mixing ladders without a clear reason wastes months and money.

Step Allergic rhinitis Deviated septum Valve collapse Polyps Sinusitis
1 Allergen avoidance Saline rinse Cottle test Steroid spray daily Saline rinse 2x daily
2 Antihistamines + steroid spray Steroid spray + nasal stent Nasal stent at night Add oral steroid course Steroid spray + GP review
3 Immunotherapy Septoplasty Valve graft surgery Biologic therapy FESS surgery
4 Biologic for severe Combined septorhinoplasty Combined septoplasty + valve repair Repeat surgery if recurrent Biologic for severe CRSwNP
Where each ladder converges
  • Saline rinses appear in every ladder; start there.
  • Steroid sprays apply to most ladders.
  • Nasal stent provides parallel mechanical support during medical treatment.
  • Surgery is always the last resort.
  • Biologics are reserved for severe inflammatory disease only.

What to expect from each treatment timeline

One of the biggest mistakes patients make is judging a treatment too soon. Each option has a typical onset and a typical maximum effect window. Plan your follow-up at the right point.

Treatment Onset of relief Maximum effect Duration
Saline rinse Immediate 1 to 2 weeks of consistent use Continuous
Antihistamine 30 minutes Same day 24 hours per dose
Intranasal corticosteroid 1 to 3 days 2 to 4 weeks While in use
Decongestant spray 10 minutes Same day Maximum 5 days
Allergen immunotherapy 3 to 6 months 3 to 5 years of treatment Years to permanent
Intranasal stent (Back2Sleep) First night 1 to 2 weeks of nightly use While worn
Septoplasty 2 to 3 weeks postop 3 to 6 months postop Permanent
FESS for sinusitis 2 to 4 weeks postop 3 months postop 5 to 10 years
Biologic for polyps 4 to 12 weeks 6 to 12 months While receiving doses
Tip from EU cliniciansKeep a 2-week symptom diary using a 0-to-10 scale before judging a new treatment. Subjective improvement is the strongest predictor of long-term adherence and outcome.

Common myths debunked

Misinformation slows down patients. The myths below are the most common across European patient surveys.

Myth 1: A deviated septum always needs surgery

False. Up to 80 percent of adults have anatomical deviation, but most need no surgery. Conservative care fixes function, not appearance.

Myth 2: Nasal sprays are addictive

Partial truth. Decongestant sprays (xylometazoline, oxymetazoline) cause rebound after 5 days. Steroid sprays (mometasone, fluticasone) are safe long term and not addictive.

Myth 3: If saline rinses helped my friend, they will help me

Partly. Saline rinses help everyone with allergic, non-allergic, or post-infectious congestion. They do not fix anatomical valve collapse alone.

Myth 4: Mouth breathing is harmless

False. Chronic mouth breathing dries the airway, reshapes facial bones in children, increases dental caries, and worsens snoring and sleep apnea risk.

Myth 5: All snoring is sleep apnea

False. Roughly 30 to 50 percent of nighttime snorers have sleep apnea. Many snore from nasal anatomy or position alone. A sleep study clarifies which group you are in.

Myth 6: Nasal stents are just nasal strips with a different shape

False. External strips lift the outer nostril walls only. Internal stents like Back2Sleep open the entire valve from inside, addressing the most common collapse point.

Myth 7: Surgery permanently fixes the problem

Partial truth. Septoplasty has 85 percent satisfaction at one year, but symptoms can return if allergies, polyps, or weight gain develop. Maintenance with sprays and rinses keeps results.

When to see a specialist immediately

Most nasal complaints are managed by GPs over weeks or months. A small number warrant urgent referral.

Red flags requiring same-week ENT review
  • One-sided block or discharge lasting more than 4 weeks.
  • Bleeding, crusting, or numbness on one side only.
  • New facial swelling or vision changes.
  • Loss of smell that does not return after a cold.
  • Witnessed pauses in breathing during sleep.
  • Snoring with morning headaches or daytime sleepiness.
  • Persistent sinus pain unresponsive to standard treatment.

Children and nasal breathing disorders

Children are particularly vulnerable. Up to 30 percent of school-age children have habitual nighttime nasal obstruction. Causes include large adenoids, tonsillar hypertrophy, allergic rhinitis, and adenotonsillar disease. The European Society for Paediatric Otorhinolaryngology (ESPO) recommends evaluation when symptoms persist for more than three months or affect sleep and growth.

Pediatric red flags

  • Snoring most nights at any age.
  • Witnessed pauses in breathing during sleep.
  • Growth slowing on the centile chart.
  • Daytime mouth open at rest.
  • Frequent sinus or ear infections.

For more on identifying child-specific signs, see recognising sleep apnea in children.

How nasal breathing affects athletic performance

Nasal breathing matters far beyond sleep. European exercise physiologists now recognise that nasal breathing through training improves endurance, recovery, and mental focus. Many endurance athletes deliberately train with nasal breathing to capture the benefits.

Why nasal breathing improves performance

  • Slower respiratory rate reduces panic-pattern hyperventilation.
  • Higher carbon dioxide tolerance shifts the oxygen-haemoglobin dissociation curve toward better tissue oxygenation.
  • Greater nitric oxide intake from sinuses dilates pulmonary capillaries.
  • More even airflow reduces airway dehydration during long efforts.
  • Better diaphragm engagement improves trunk stability.

What this means for snorers and people with nasal disorders

If your nose cannot keep up with your respiratory demand, you compensate by mouth breathing. The compensation costs energy, accelerates fatigue, and disrupts heart-rate variability. Treating the nasal disorder first lets your body return to its preferred breathing pattern day and night.

Daytime fix, nighttime fix
  • Treat the underlying nasal disorder.
  • Practice slow nasal breathing for 5 minutes daily.
  • Wear a Back2Sleep stent at night during high-load training weeks.
  • Use saline rinses to keep the airway lining healthy.
  • Repeat the diagnostic step if performance does not improve in 4 to 8 weeks.

Country-by-country specialist access in Europe

The route to specialist care varies. The differences are operational, not philosophical, since EU-wide guidelines are largely aligned. Knowing the local pathway saves weeks of delay.

France

The médecin traitant refers to an oto-rhino-laryngologiste (ORL). Polysomnography or polygraphy through a centre du sommeil agreed by the Sécurité Sociale. Allergology covered through public consultation. Septoplasty waiting times of 2 to 6 months in public hospitals.

Germany

The Hausarzt refers to an HNO-Arzt (otorhinolaryngologist). GKV (statutory) and PKV (private) cover both. Allergy testing through specialist Allergologe. Schlaflabor (sleep lab) referral common for moderate symptoms.

UK

The NHS GP refers to ENT through Choose and Book. Waits range from 6 to 18 weeks for non-urgent referral. Private ENT consultation typically 200 to 350 pounds.

Spain

The médico de cabecera refers to otorrinolaringología through SNS hospitals. Private mutuas (Adeslas, Sanitas, DKV) provide faster specialist access. Allergology widely available.

Italy

The medico di medicina generale refers via the Sistema Sanitario Nazionale. Region-specific timing; CUP booking system handles appointments. Private clinics common as faster route.

Netherlands

The huisarts refers to KNO (otorhinolaryngology) at hospital outpatient clinics. Zorgverzekering basic policy covers ENT and surgery. Eigen risico applies (own risk excess).

Practical tipIf your public-system wait is too long, several EU countries allow private consultation reports to be transferred back into public-system surgical pathways. Ask your GP if private diagnosis can shortcut your route to a public-system procedure.

How Back2Sleep fits the broader nasal disorder map

Back2Sleep is not a one-size-fits-all solution. It sits in a specific role within the broader treatment ladder. Understanding when it helps and when it does not prevents disappointment.

Best fits

  • Adults with nasal valve collapse confirmed by Cottle test.
  • Adults with mild deviated septum awaiting or avoiding surgery.
  • Adults with turbinate hypertrophy contributing to nighttime obstruction.
  • Adults with snoring from nasal anatomy alone.
  • Adults with mild to moderate OSA seeking a non-medication adjunct.
  • Travellers needing a portable, electricity-free option for hotels.

Not a fit

  • Severe OSA with high apnea-hypopnea index (CPAP is required).
  • Active nasal infection or severe rhinitis without prior treatment.
  • Recent nasal surgery in the past 6 weeks.
  • Children under medical supervision for OSA.
  • Pregnancy with severe OSA (CPAP first line).

How it complements other treatments

Many patients combine the Back2Sleep nasal stent with other non-surgical care. Saline rinses cleanse the nasal lining before insertion. Steroid sprays reduce mucosa swelling so the stent fits comfortably. Antihistamines manage allergies in season. Side sleeping enhances effect for positional snorers. Used together, the combined effect often surpasses any single intervention.

Combining Back2Sleep with other care
  • Use saline rinse 30 minutes before insertion.
  • Apply your steroid spray daily as recommended by GP.
  • Stay on antihistamines during peak allergy season.
  • Sleep on your side; combine with a side-sleep pillow if needed.
  • Replace each stent regularly per pack instructions.

Long-term outlook

Most nasal breathing disorders are manageable with consistent care. Even those that require surgery often improve dramatically with the right intervention. The keys are accurate diagnosis, the right ladder, and adherence over months not days.

Five-year outlook by disorder

Disorder 5-year outcome with EU standard care
Deviated septum (mild) 80 percent symptom-free with conservative care alone
Deviated septum (severe) 85 percent satisfied after septoplasty
Nasal valve collapse 70 percent improved with stent or graft surgery
Allergic rhinitis 60 percent symptom reduction with sprays; 80 percent with immunotherapy
Non-allergic rhinitis 70 percent improved with trigger avoidance + sprays
Nasal polyps 50 percent recurrence by 5 years; biologics reduce recurrence
Turbinate hypertrophy 80 percent improved with conservative care
Chronic sinusitis 75 percent improved with FESS, recurrence in 25 percent
Chronic mouth breathing 65 percent reverse to nasal breathing within 1 year of cause treatment

The Back2Sleep starter kit, at 39 euros for 4 sizes (XS to L) and a 30-day money-back option, is one of the most accessible entry points into European at-home care for nasal-driven snoring and mild OSA. It does not replace medical treatment but supports it through the months and years of conservative care that most patients need.

Frequently overlooked contributors

Some causes of chronic nasal blockage do not show up on a routine ENT exam but contribute to symptoms in many patients.

Hormonal rhinitis

Pregnancy, menstrual cycle, hormonal contraception, hypothyroidism, and acromegaly all alter nasal mucosa. Pregnancy rhinitis affects up to 30 percent of pregnant women, peaking in the third trimester.

Medication-induced rhinitis

ACE inhibitors, beta-blockers, alpha-blockers, sildenafil, and contraceptive pills can cause nasal congestion. Cocaine, marijuana, and inhaled stimulants damage the nasal lining permanently with repeated use.

Reflux and laryngopharyngeal irritation

Acid reflux during sleep irritates the upper airway and post-nasal area. Diet, weight, and bed elevation help. A trial of proton pump inhibitor under medical supervision is sometimes recommended.

Occupational exposure

Bakery flour dust, hairdresser chemicals, woodworking dust, cleaning agents, and welding fumes cause occupational rhinitis. EU occupational health frameworks support workplace adjustments.

Sleep posture and pillow choice

A pillow that is too flat or too thick changes head position and worsens nasal obstruction. The ideal pillow keeps the spine neutral and the head slightly elevated to reduce mucosa congestion.

Frequently asked questions

What are the main types of nasal breathing disorders?

The main nasal breathing disorders are deviated septum, nasal valve collapse, allergic rhinitis, non-allergic chronic rhinitis, nasal polyps, turbinate hypertrophy, chronic sinusitis, and chronic mouth breathing. Each has distinct anatomical or inflammatory causes and different first-line treatments in European care pathways.

How do I know if I have nasal valve collapse?

Press lightly on each cheek next to the nostril while breathing in. If breathing improves dramatically, you likely have nasal valve collapse. ENT specialists confirm it with the modified Cottle test and nasal endoscopy. Valve collapse is often missed because rhinoscopy alone shows a normal-looking nose.

Can a nasal stent fix nasal valve collapse without surgery?

A soft silicone intranasal stent like Back2Sleep mechanically holds the valve open during sleep, addressing the same area that surgery would widen. For mild to moderate valve collapse with snoring, it provides immediate relief at 39 euros versus surgery, which costs hundreds to thousands of euros and weeks of recovery.

Which nasal sprays help chronic congestion safely in Europe?

Mometasone furoate and fluticasone propionate are intranasal corticosteroids available over the counter in most EU countries. They reduce inflammation and shrink turbinates over two to four weeks. Decongestant sprays containing xylometazoline or oxymetazoline must not be used for more than five consecutive days because of rebound congestion.

When does a deviated septum require surgery?

Septoplasty is recommended when conservative therapy fails for at least three months and a clear anatomical block obstructs more than 50 percent of the airway. EU public systems generally cover the procedure for documented sleep impact, recurrent sinusitis, or persistent nasal obstruction confirmed by ENT examination and imaging.

What is mouth breathing and why is it harmful?

Chronic mouth breathing means habitually breathing through the mouth instead of the nose, often during sleep or at rest. It dries the airway, raises sleep apnea risk, alters facial development in children, increases dental caries, and reduces nitric oxide uptake from the nasal lining.

Are nasal polyps cancerous?

Nasal polyps are benign soft growths in the lining of the nose and sinuses, not cancer. They are linked to chronic inflammation, asthma, and aspirin sensitivity. Persistent unilateral mass, bleeding, or numbness should always be evaluated by an ENT specialist with nasal endoscopy and imaging.

Can saline rinses really replace medication for nasal congestion?

Saline rinses with a neti pot or squeeze bottle reduce congestion, allergic load, and post-nasal drip. Used twice daily, they cut symptom scores by 30 to 40 percent and reduce reliance on sprays. Always use sterile or boiled and cooled water to prevent rare amoeba infections.

Infographic about Nasal Breathing Disorders: A Comprehensive 2026 Patient Guid
Medical disclaimer

This article is for general information only and does not replace medical advice. Consult a qualified healthcare professional in your country for diagnosis and personalised treatment of nasal disorders or sleep apnea.

What Back2Sleep Users Say

★★★★☆
"Day 1: The tube is easy to insert but it made me feel nauseous. Day 2: I managed with the shortest tube and felt better. Days 3-4: I moved to size M and got used to the feeling in my throat. I woke up and I wasn't tired! No more heavy legs or fatigue. Tonight I'm trying size L."
— Greg Verified Amazon Purchase
★★★★★
"Since I started using the Back2Sleep Starter Kit, my quality of life has literally changed. I had significant snoring problems that disturbed not only my sleep but also my partner's. From the very first use, I noticed a clear improvement: I breathe better, I sleep more deeply, and I wake up more rested. This kit is not only effective but also very comfortable to wear all night. I highly recommend it to anyone who suffers from snoring or mild apnea. The value for money is excellent and the results are impressive!"
— Alex Verified Amazon Purchase
★★★★★
"Significantly reduces snoring. Super product!"
— Choufred Verified Amazon Purchase

Ready for quieter nights? Discover the Back2Sleep starter kit and find the right fit for you.

Not sure if you are at risk? Take our sleep risk screening to find out in just a few minutes.

Want to learn how it works? Explore the Back2Sleep nasal stent designed for comfortable, effective relief.

Say stop to sleep apnea and snoring!
Back2Sleep packaging with sheep to represent a deep sleep
I try! Starter Kit
Back to blog